|
inhibitor
|
CHEBI_35222 |
[A substance that diminishes the rate of a chemical reaction.] |
|
Cuneus
|
FMA_61903 |
|
|
Precuneus
|
FMA_61900 |
|
|
personality disorder
|
DOID_1510 |
[A disease of mental health that involve long-term patterns of thoughts and behaviors that cause serious problems with relationships and work.] |
|
steroid hormone
|
CHEBI_26764 |
[Any steroid that acts as hormone.] |
|
RB1CC1
|
OGG_3000009821 |
|
|
MAOB
|
OGG_3000004129 |
|
|
PPARG
|
OGG_3000005468 |
|
|
ALPK2
|
OGG_3000115701 |
|
|
CCR9
|
OGG_3000010803 |
|
|
NUPL1
|
OGG_3000009818 |
|
|
MAPT
|
OGG_3000004137 |
|
|
PPARA
|
OGG_3000005465 |
|
|
ATXN1
|
OGG_3000006310 |
|
|
STK11
|
OGG_3000006794 |
|
|
protectin D1
|
CHEBI_138655 |
[A dihydroxydocosahexaenoic acid that is (4Z,7Z,11E,13E,15Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at positions 10 and 17 (the 10R,17S-stereoisomer). Protectin D1 is one of the specialised proresolving mediators. When produced in neural tissues, it is called neuroprotectin D1] |
|
zone of organ
|
UBERON_0034944 |
|
|
Phospholipase D
|
OMIT_0011724 |
|
|
Type C Phospholipases
|
OMIT_0011723 |
|
|
endothelial cell activation
|
GO_0042118 |
[The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.] |
